"If there’s a book that you want to read, but it hasn’t been written yet, then you must write it.” Thanks to all the amazing authors, from east to west, who contributed to this incredible journey. Stay tuned for the printed copy! @SpringerNature @FrancescaRatti3

October Issue: Conversion to Resection After Neoadjuvant #Gemcitabine , #Cisplatin , and #NabPaclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis @Yawwenyy @TELL_Starlinger @vanjapod https://t.co/gyfLn7l0Ec @_BrainyMD_ @SyedAAhmad5

From the October Issue of @AnnSurgOncol: Conversion to Resection After Neoadjuvant #Gemcitabine , #Cisplatin , and #NabPaclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis @Yawwenyy @TELL_Starlinger @vanjapod https://t.co/CtBUiRpLDJ @_BrainyMD_ @SyedAAhmad5

New insights from a @MayoClinic links a genetic variation to chemotherapy-related liver damage in patients with colorectal cancer liver metastases. This could be a step toward more tailored, effective care for advanced #ColonCancer. https://t.co/8DYG8OzUst @TELL_Starlinger

Treatment strategies for de novo perihilar cholangiocarcinoma (pCCA) - a rare and aggressive #BileDuctCancer - are evolving. A recent @MayoClinic study compares outcomes of liver transplant vs. resection after chemoradiation. Learn more: https://t.co/M5HzmhrqZe

@UGrewalMD Absolutely! Reviewing images in person is so helpful, as I have found with @OncoThor, @PatrickMcGarrah, and @TELL_Starlinger. AND I gently remind fellow NET pts that rads are not yet the Borg (Star Trek, IYKYK) and so reports are truly interpretations, even in 2025! 🤯😅

The presence of carcinoid syndrome (CS) in patients with sbNETs and liver mets undergoing debulking predicts worse survival and is, not surprisingly, associated w/ larger mets. Despite short PFS, OS is still long. Pts w/o CS can develop it over time https://t.co/wdyA2DU4YZ

Chemotherapy-Associated Liver Injury Elevated by Genetic Variant in CRLM A variant in the PNPLA3 gene is associated with a heightened risk of CALI in patients receiving neoadjuvant chemotherapy for CRLM @TELL_Starlinger @MayoClinic #CALI #CRC #metastasis https://t.co/xlPVcnRXg0

A recent @MayoClinic study compared outcomes of liver resection and liver transplantation after chemoradiation for treating de novo perihilar cholangiocarcinoma (pCCA), a rare and aggressive #BileDuctCancer. Learn more: https://t.co/M5HzmhrqZe

Mayo Clinic in Rochester has been named the No. 1 smart hospital in the world by Newsweek's "World's Best Smart Hospitals 2026" and earned more No. 1 specialty rankings than any other hospital in the "World's Best Specialized Hospitals 2026" list. More: https://t.co/M55oMjwvHs

Preoperative von Willebrand factor predicts liver failure risk. by Dong Y, Gregory LA (...) Starlinger PP et 11 al. in Liver Transpl 🪡 read our summary 👉 https://t.co/DI6ATq5tRZ. 📖 read the article:

@TheNotoriousHPB So true. Patients are inclined to accept the certainty of "unresectable liver mets", even when it comes from a med onc and not a practiced HPB surg onc. I'm lucky that my awesome NET specialist doesn't pretend to be a surgeon - it takes a team. @OncoThor @TELL_Starlinger

When local surgeons told him his tumor was inoperable, CV Rao wanted a second opinion. After meeting with clinicians at @MayoClinic, he was given renewed hope that he was at the right place for help. https://t.co/hHPpZ29QTe @TELL_Starlinger #Cholangiocarcinoma #BileDuctCancer

It’s officially out. Make sure to order your copy. 👇🏼👇🏼 @SSATNews @ElsevierConnect @AuroraPryor @patsyllamd @aprabhumd1 @juliomayol @TomVargheseJr @UCincySurg @uofcincycancer @CincyMedicine @uc_health

The @UofTSurgery community mourns the loss of cherished colleague, Dr. Sean Cleary. "Sean has touched the lives of many of us – as a clinical colleague, teacher, mentor, supervisor, confidential advisor, and friend. . ." Read the Chair's message at https://t.co/oS8FnBkV9C

A recent study led by @MayoClinic researchers analyzed long-term outcomes of #hepatectomy in patients with advanced #LiverCancer caused by #NeuroendocrineTumors (NETs). Read more about the study: https://t.co/Ym40P430Dh

After local surgeons deemed his tumor inoperable, CV Rao wanted a second opinion. He met with @MayoClinic #HPB surgeon @TELL_Starlinger, who was able to provide renewed hope for treatment. Read CV's story:

What are the causes of death in patients following cytoreductive hepatectomy for NET liver mets...? Here you have data! 2/3 tumor related, 1/3 not. Liver failure and bowel obstruction are leading causes. Higher grade, shorted PFS and age predictors. https://t.co/quVJjgdmet

Exciting news! The Department of Surgery’s Complex General Surgical Oncology Fellowship at Mayo Clinic has matched our fellow for 2026–2028. Welcome to the team — we’re thrilled to have you join us! #FellowMatch #SurgicalOncology #MayoClinicMN @ThielsCA

Fortunate to be able to celebrate my friend Prof James Shapiro as the 2025 BJS Award recipient at the Royal College of Surgeons yesterday evening. His innovative work in islet transplantation (Edmonton Protocol) has had extraordinary impact. @BJSurgery @BjsOpen @BJSAcademy